NXT Ventures
VC Fund
Marblehead, United States
NXT Ventures is a VC fund in Marblehead focused on Software and Manufacturing. NXT Venture Fund is established for the purpose of discovering and enabling the next truly disruptive start-up companies, with potential to transfer and create cross-border synergies between US and China.
- Total investments:
- 66
- Last investment:
- Lead investor:
- 11%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries NXT Ventures invests in
Stages NXT Ventures invests in
Countries NXT Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $455k–$3.5M
- Series A
- $3.3M–$19M
- Venture - Series Unknown
- $320k–$12M
Investment Focus
Industry
- Software 9 (14%)
- Manufacturing 8 (12%)
- Artificial Intelligence 8 (12%)
- Analytics 7 (11%)
- SaaS 6 (9%)
Stage
- Seed 31 (47%)
- Venture - Series Unknown 10 (15%)
- Series A 8 (12%)
- Series B 4 (6%)
- Funding Round 3 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jared Jaffe
Senior Associate
|
Senior Associate | Total investments: 0 | Find email | |
Raymond Chang
Managing Director
|
Managing Director | Total investments: 11 | Find email | |
|
Steve jones
Founder / CEO
|
Founder / CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Raven360 empowers enterprises of all sizes to control intellectual property and other valuable content as it is shared externally. | $8M / Series B / Aug 04, 2022 | ||
| Clinical Research IO is a health tech company developing eSource technology to streamline clinical research workflow. It assists pharma, biotech, research sites, and academic research centers streamlines regulatory workflows with one system that enables a single point of data capture. | $9M / Series B / Jan 12, 2022 | ||
| Clinical Research IO is a health tech company developing eSource technology to streamline clinical research workflow. It assists pharma, biotech, research sites, and academic research centers streamlines regulatory workflows with one system that enables a single point of data capture. | $3.5M / Series A / Feb 28, 2021 | ||
| Clinical Research IO is a health tech company developing eSource technology to streamline clinical research workflow. It assists pharma, biotech, research sites, and academic research centers streamlines regulatory workflows with one system that enables a single point of data capture. | $1.4M / Convertible Note / Mar 01, 2020 | ||
| Luminopia develops a new class of treatments for significant neuro-visual disorders. The company is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One, totreat amblyopia, the cause of vision loss among children. | $4.8M / Seed / Mar 01, 2020 | ||
| Connectbase utilizes location-based insights and automation to buy and sell connectivity. Its platform drives growth for the clients by increasing visibility to the market, managing location, and driving engagement as the system of record where connectivity providers connect and pass by in the commercial market. | $5.3M / Series A / Jul 30, 2019 | ||
| Ambi is designed to centralize the college experience for students through a productive and powerful social network, essentially becoming a hub for people to connect, communicate, engage and collaborate with everyone and everything at a given school. Yesterday’s campus technology wasn’t built for today’s students. Today’s students are busy,stressed, and yearning to connect. They need a centralized learning experience that meets them where they are and keeps them engaged on the go. Enter ambi.Ambi is a Learner Engagement Platform designed for students first, creating a more engaged, involved and immersive learning experience for everyone. Ambi's vision is to change how the world learns by engaging today's students, together.We are a team of passionate, curious and creative people who find purpose in our work and support each other in the process. If you're interested in joining, reach out, we would love to talk to you! | $5M / Series A / Dec 18, 2018 | ||
| CHASM’s mission is to develop and manufacture advanced carbon nanomaterials, leveraging our innovative product platforms to create a safer, more connected, and more sustainable world.The company's objective since its establishment in 2015 has been to create innovative materials with the potential to greatly improve performance, cost, andsustainability for global solutions. CHASM is defined by the best carbon nanotube (CNT) technology available, along with their exceptional capacity to incorporate nanotubes into game-changing applications. | $11M / Series A / Oct 02, 2018 | ||
| NestReady is bridging the gap between home discovery and financing. We simplify the home buying process by integrating mortgage and real estate into one seamless service. Thanks to our white-label plug and play platform, mortgage lenders can better understand their clients, save on customer acquisition costs, and offer a complete homebuyingexperience directly on their website. | $5.7M / Venture - Series Unknown / Sep 24, 2018 | ||
| Lionano Inc. is a material manufacturing company commercializing an advanced drop-in replacement material for the lithium-ion batteries. The company focuses on improving the key components of lithium-ion batteries. The material has been nano-engineered to create batteries with greater capacity and cycle life. This technology can enable lighter andlower-cost consumer electronics and longer range for electric vehicles. The technology has been fully developed at Cornell University and Lionano is ready to launch the product. Lionano is led by a combination of unique people: a recent PhD graduate in Chemistry at Cornell University, an MBA from Cornell's Johnson School, a distinguished Professor in electrochemistry research at Cornell University, and an experienced battery industry expert.Lionano was founded in 2013 and is headquartered in Woburn, Massachusetts, USA. | $22M / Series B / Sep 24, 2018 | ||
| See all 66 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does NXT Ventures invest in?
NXT Ventures invests primarily in Software, Manufacturing and Artificial Intelligence startups, most often at Seed and Venture - Series Unknown stage. Most of the 66 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does NXT Ventures invest in?
NXT Ventures typically joins rounds of $455k–$3.5M at Seed, $3.3M–$19M at Series A and $320k–$12M at Venture - Series Unknown. These are whole funding-round sizes, not NXT Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds NXT Ventures took part in.
How do I contact NXT Ventures?
Public channels for NXT Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NXT Ventures?
The team at NXT Ventures includes Jared Jaffe (Senior Associate), Raymond Chang (Managing Director) and Steve jones (Founder / CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
